Mediators of Inflammation / 2013 / Article / Tab 4

Clinical Study

Inflammation, Haemostatic Disturbance, and Obesity: Possible Link to Pathogenesis of Diabetic Retinopathy in Type 2 Diabetes

Table 4

Odds ratios (95% CIs) for diabetic retinopathy associated with basic characteristics, inflammatory and haemostatic markers, other markers of endothelial dysfunction, and anthropometric and clinical parameters in type 2 diabetic patients ( ).

OR95% CI (OR)AOR*95% CI (AOR)

Diabetes duration (years)1.171.08–1.271.21.1–1.32
Therapy (insulin)3.341.38–8.093.281.34–8.02
C-reactive protein (CRP)1.070.98–1.181.080.99–1.18
Fibrinogen1.010.74–1.380.990.71–1.37
HbA1c1.180.83–1.681.230.85–1.77
HbA1cmedian1.761.08–2.861.841.10–3.06
Total cholesterol1.010.68–1.511.030.68–1.57
Triglycerides0.890.69–1.130.900.70–1.15
Body mass index (BMI)0.990.93–1.060.990.92–1.07
Waist circumference (WC)1.000.97–1.031.010.98–1.04
Waist-to-hip ratio (WHR)1.340.01–185.057.420.14–3806.64
Systolic blood pressure1.021.00–1.031.021.00–1.04
Diastolic blood pressure0.980.95–1.010.980.95–1.02

Bold: statistically significant , *OR adjusted for age and sex.
HbA1c: glycated hemoglobin value determined at the beginning of the study from a single venous blood sample; HbA1cmedian: glycated hemoglobin value obtained by statistical analysis of data from the National Registry for Diabetes (CroDiabNet).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.